US adds three genomics companies to its UFLPA Entity List
DHS’s 29 October notice adds BGI Genomics, MGI Tech and Shenzhen BGI Technology. Sellers of potentially connected equipment, reagents or other goods should check the actual manufacturer and supply chain with the US importer before dispatch.
- Who this affects
- Specialist sellers and importers of goods potentially produced by the three named genomics companies, or involving their inputs.
- Seller action
- Check before sending affected goods
Check the actual manufacturer and supply chain before US dispatch. Resolve possible matches with the US importer and broker; an extra duty payment does not resolve an admissibility issue.
- Effective dates / current position
- Published UFLPA entity-list update: — In forceTiming follows the confirmed published schedule; it is not a fresh legal review. Date-only changes use the calendar day in America/New York.
- Last reviewed
- 30 Oct 2026 — an editorial source check, separate from automatic timing.
- Official source
- Open the primary source ↗
What has been published?
The Department of Homeland Security’s final notice, published on 29 October 2026, adds three companies to the Uyghur Forced Labor Prevention Act (UFLPA) Entity List:
- BGI Genomics Co., Ltd.
- MGI Tech Co., Ltd.
- Shenzhen BGI Technology Co., Ltd.
The notice identifies businesses involved in genomics, life-science instruments, reagents and related products. It does not identify every affected retail model or SKU. A brand name or product category alone is not enough to decide whether a particular shipment is covered.

Why the manufacturer matters
UFLPA requires US Customs and Border Protection to apply a rebuttable presumption against entry of goods covered by the Act, including goods produced by a listed entity. The underlying law also addresses goods made wholly or partly in Xinjiang. Do not assume a UK reseller invoice or dispatch address resolves the production question.
The exception process requires the importer to meet the statutory conditions, respond fully to CBP’s inquiries and provide clear and convincing evidence. Release is not guaranteed. There is no shipment-value exception in section 3 of the Act.
Practical checks before shipping
- Identify the actual producer. Obtain the legal manufacturer name and model-specific production information, rather than relying only on the distributor’s trading name.
- Check relevant inputs. Ask the supplier whether a listed company produced the goods or supplied an incorporated component or material. Escalate unclear answers to the US importer or specialist adviser.
- Keep traceability records. Retain purchase, manufacturing and shipment documents together so the importer can assess coverage and respond to customs.
- Resolve possible matches before dispatch. Ask the importer and broker which evidence and procedure are needed. Paying extra duty does not settle an admissibility problem.
This guidance concerns the three additions in the published notice. Use the latest official list for ongoing screening; later additions, removals or corrections can change it. Unrelated stock should continue through the normal US product and customs checks.
Official sources
- DHS final notice 2026-22094 and entity-list appendix, published 29 October 2026 (PDF) — the three legal company names and the published update.
- Public Law 117-78, section 3 (PDF) — presumption and exception requirements.
- DHS UFLPA Entity List — ongoing screening. The live list page was unavailable during this review; the additions above were checked against the final published notice and appendix.
Updates to this article
First published after checking DHS’s final 29 October notice, its entity-list appendix and UFLPA section 3. Scoped to specialist manufacturer and supply-chain checks; government publication date is separate from first site publication.